Narrative review / 2010
A review discusses how gut microbiota alterations, barrier dysfunction, and immune changes may play a role in chronic fatigue syndrome.
This review examines the interplay between gut microecology, mucosal barrier function, and the immune system in chronic fatigue syndrome (CFS). The authors note that CFS patients frequently report gut dysfunction, IBS diagnoses, and related symptoms. Altered intestinal microbiota, mucosal barrier dysfunction facilitating bacterial translocation, and altered mucosal immunity may modulate enteric nervous system activity. Modifying gut microbiota through approaches such as probiotics is discussed as a potential means to alter microbiota, improve mucosal barrier function, reduce pro-inflammatory cytokines, and potentially improve gut motility and mood.
- Study type
- Narrative review
- Who was studied
- Patients with chronic fatigue syndrome (CFS)
- What was measured
- Gut microbiota, mucosal barrier function, immune system, and potential probiotic therapy
THE PAPER
Gut inflammation in chronic fatigue syndrome.
Lakhan SE, Kirchgessner A. Nutr Metab (Lond), 2010.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.